Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy. 1993

F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
Institute of Child Neurology and Psychiatry, Cagliari, Italy.

Dystrophin, the protein product of the Duchenne muscular dystrophy (DMD) gene, was studied in 19 patients with Xp21 disorders and in 25 individuals with non-Xp21 muscular dystrophy. Antibodies raised to seven different regions spanning most of the protein were used for immunocytochemistry. In all patients specific dystrophin staining anomalies were detected and correlated with clinical severity and also gene deletion. In patients with Becker muscular dystrophy (BMD) the anomalies detected ranged from inter- and intra-fibre variation in labelling intensity with the same antibody or several antibodies to general reduction in staining and discontinuous staining. In vitro evidence of abnormal dystrophin breakdown was observed reanalysing the muscle of patients, with BMD and not that of non-Xp21 dystrophies, after it has been stored for several months. A number of patients with DMD showed some staining but this did not represent a diagnostic problem. Based on the data presented, it was concluded that immunocytochemistry is a powerful technique in the prognostic diagnosis of Xp21 muscular dystrophies.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009136 Muscular Dystrophies A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS. Muscular Dystrophy,Myodystrophica,Myodystrophy,Dystrophies, Muscular,Dystrophy, Muscular,Myodystrophicas,Myodystrophies
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002891 Chromosomes, Human, Pair 21 A specific pair of GROUP G CHROMOSOMES of the human chromosome classification. Chromosome 21

Related Publications

F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
October 1993, Journal of neurology, neurosurgery, and psychiatry,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
January 1989, Neuron,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
December 2005, Neurology,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
May 1991, No to shinkei = Brain and nerve,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
December 1993, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
December 1992, Arquivos de neuro-psiquiatria,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
January 2004, Neurological research,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
January 1992, Pediatric neurology,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
May 1990, Journal of medical genetics,
F Muntoni, and A Mateddu, and C Cianchetti, and M G Marrosu, and A Clerk, and M Cau, and R Congiu, and A Cao, and M A Melis
January 1995, Revista de neurologia,
Copied contents to your clipboard!